Apollon raises $3.8M series a
Announced 23 September 2026
◆ The Round
Apollon raised $3.8M in series a funding, announced on 23 September 2026, led by SBI Investment, with participation from Naver, Daewoong, Korea Credit Guarantee Fund, Mirae Holdings. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.
◆ About Apollon
Developer of non-invasive continuous glucose monitoring (CGM) devices using Raman spectroscopy. Apollon is based in South Korea and currently at series a stage, operating in Medtech.
◆ Investors
LeadSBI Investment
ParticipationNaver, Daewoong, Korea Credit Guarantee Fund, Mirae Holdings
◆ Market context
This funding event is a citable node in Fusion42's market graph: it links Apollon's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.
◆ Explore the market
◆ FAQ
How much did Apollon raise?
Apollon raised $3.8M in its series-a round, announced 2026-09-23.
Who invested in Apollon's series-a round?
The round was led by SBI Investment, with participation from Naver, Daewoong, Korea Credit Guarantee Fund and Mirae Holdings.
What does Apollon do?
Developer of non-invasive continuous glucose monitoring (CGM) devices using Raman spectroscopy.
Verified 24 September 2026 · Sources: public filings